1.52
price up icon14.29%   0.19
after-market アフターアワーズ: 1.50 -0.02 -1.32%
loading
前日終値:
$1.33
開ける:
$1.32
24時間の取引高:
238.61K
Relative Volume:
0.09
時価総額:
$35.96M
収益:
-
当期純損益:
$-87.23M
株価収益率:
-0.5118
EPS:
-2.97
ネットキャッシュフロー:
$-82.77M
1週間 パフォーマンス:
+38.18%
1か月 パフォーマンス:
-14.12%
6か月 パフォーマンス:
-82.57%
1年 パフォーマンス:
-85.57%
1日の値動き範囲:
Value
$1.28
$1.54
1週間の範囲:
Value
$1.11
$1.54
52週間の値動き範囲:
Value
$0.8801
$19.30

Pepgen Inc Stock (PEPG) Company Profile

Name
名前
Pepgen Inc
Name
セクター
Healthcare (1155)
Name
電話
703-456-8000
Name
住所
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Name
職員
81
Name
Twitter
Name
次回の収益日
2024-11-08
Name
最新のSEC提出書
Name
PEPG's Discussions on Twitter

PEPG を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PEPG
Pepgen Inc
1.52 35.96M 0 -87.23M -82.77M -2.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Pepgen Inc Stock (PEPG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-16 ダウングレード BofA Securities Neutral → Underperform
2024-07-31 ダウングレード BofA Securities Buy → Neutral
2022-12-21 開始されました H.C. Wainwright Buy

Pepgen Inc (PEPG) 最新ニュース

pulisher
05:11 AM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc.PEPG - Bluefield Daily Telegraph

05:11 AM
pulisher
Apr 15, 2025

Is PepGen (NASDAQ:PEPG) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Apr 15, 2025
pulisher
Apr 09, 2025

PepGen Inc.’s CEO Makes Bold Stock Purchase! - TipRanks

Apr 09, 2025
pulisher
Apr 09, 2025

PepGen president and CEO McArthur buys shares worth $47,724 By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 09, 2025

PepGen president and CEO McArthur buys shares worth $47,724 - Investing.com

Apr 09, 2025
pulisher
Apr 08, 2025

PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 05, 2025

PepGen stock plunges to 52-week low of $1.14 amid market challenges - Investing.com Canada

Apr 05, 2025
pulisher
Apr 04, 2025

PepGen stock plunges to 52-week low of $1.14 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

PepGen (NASDAQ:PEPG) Stock Price Down 14.4% – Time to Sell? - Defense World

Apr 04, 2025
pulisher
Apr 02, 2025

PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference - BioSpace

Apr 02, 2025
pulisher
Apr 01, 2025

PepGen Announces Appointment of Two New Directors to its Board - BioSpace

Apr 01, 2025
pulisher
Mar 31, 2025

PepGen Appoints Lisa Wyman and Mitchell Finer to its Board of Directors - citybiz

Mar 31, 2025
pulisher
Mar 31, 2025

PepGen Inc. Expands Board with New Appointments - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

PepGen names two new directors to board - TipRanks

Mar 31, 2025
pulisher
Mar 28, 2025

PepGen CMO Mellion resigns, effective April 4 - Investing.com Australia

Mar 28, 2025
pulisher
Mar 28, 2025

PepGen CMO Mellion resigns, effective April 4 By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 26, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen IncPEPG - Bluefield Daily Telegraph

Mar 26, 2025
pulisher
Mar 18, 2025

PEPG ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of PepGen Inc. Shareholders Who Lost Money - ACCESS Newswire

Mar 18, 2025
pulisher
Mar 10, 2025

PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference - Business Wire

Mar 10, 2025
pulisher
Mar 10, 2025

PepGen Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsPEPG - ACCESS Newswire

Mar 10, 2025
pulisher
Mar 05, 2025

PepGen Inc. Faces Clinical Trial Challenges and Competitive Pressures Leading to Sell Rating - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

What Do Analysts Think Will Happen To PepGen Inc (NASDAQ: PEPG) - Stocks Register

Mar 05, 2025
pulisher
Mar 05, 2025

PepGen pauses Phase II DMD trial to review safety data - Yahoo Finance

Mar 05, 2025
pulisher
Mar 04, 2025

PepGen To Voluntarily Pause Mid-Stage Duchenne Muscular Dystrophy Study, Stock Falls - Benzinga

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Boston biotech's stock drops after Duchenne trial pause - The Business Journals

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen to pause CONNECT2-EDO51 study - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen slumps after pausing mid-stage study of Duchenne drug - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen pauses phase 2 DMD study to review earlier trial data - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMD -March 04, 2025 at 08:18 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen stock slides after trial pause (PEPG:NASDAQ) - Seeking Alpha

Mar 04, 2025
pulisher
Mar 04, 2025

Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMD - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen to Participate in Upcoming Investor Conferences - Business Wire

Mar 04, 2025
pulisher
Mar 04, 2025

AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - Asianet Newsable

Mar 04, 2025
pulisher
Mar 03, 2025

PepGen Sees Fastest Weekly Retail Following Growth Among Biotech Stocks: What's Behind The Buzz? - Asianet Newsable

Mar 03, 2025
pulisher
Mar 03, 2025

PepGen (PEPG) to Release Quarterly Earnings on Wednesday - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

PEPG Stock Price and Chart — NASDAQ:PEPG - TradingView

Mar 02, 2025
pulisher
Mar 01, 2025

Q1 Earnings Estimate for PepGen Issued By HC Wainwright - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Q1 Earnings Forecast for PepGen Issued By Leerink Partnrs - MarketBeat

Feb 28, 2025

Pepgen Inc (PEPG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
大文字化:     |  ボリューム (24 時間):